You just read:

Abbott Presents Phase 3 Study Results for Investigational Use of HUMIRA® (Adalimumab) in Patients with Active Non-radiographic Axial Spondyloarthritis

News provided by

Abbott

06 Jun, 2012, 06:05 BST